These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11470581)

  • 1. Gene therapy versus protein-based therapy: a matter of pharmacokinetics.
    Post MJ; Simons M
    Drug Discov Today; 2001 Aug; 6(15):769-770. PubMed ID: 11470581
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic considerations regarding non-viral cancer gene therapy.
    Nishikawa M; Takakura Y; Hashida M
    Cancer Sci; 2008 May; 99(5):856-62. PubMed ID: 18294288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
    Crémieux AC; Katlama C; Gillotin C; Demarles D; Yuen GJ; Raffi F;
    Pharmacotherapy; 2001 Apr; 21(4):424-30. PubMed ID: 11310515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of intravitreal drug pharmacokinetics: does it matter? and if so, how?
    Stewart MW
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):5-7. PubMed ID: 29221430
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of protein binding in pharmacokinetics and pharmacodynamics.
    Schmidt S; Gonzalez D; Derendorf H
    J Pharm Sci; 2010 Mar; 99(3):1107-22. PubMed ID: 19852037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions in older adults: which ones matter?
    Hanlon JT; Schmader KE
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):61-3. PubMed ID: 16129382
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
    Aweeka FT; Rosenkranz SL; Segal Y; Coombs RW; Bardeguez A; Thevanayagam L; Lizak P; Aberg J; Watts DH;
    AIDS; 2006 Sep; 20(14):1833-41. PubMed ID: 16954724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of milk replacer feeding rate and long-term antibiotic inclusion in milk replacer on performance and nutrient digestibility of Holstein dairy calves up to 4 months of age.
    Dennis TS; Suarez-Mena FX; Hu W; Hill TM; Quigley JD; Schlotterbeck RL
    J Dairy Sci; 2019 Mar; 102(3):2094-2102. PubMed ID: 30639003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free drug fraction vs free drug concentration: a matter of frequent confusion.
    Toutain PL; Bousquet-Melou A
    J Vet Pharmacol Ther; 2002 Dec; 25(6):460-3. PubMed ID: 12485352
    [No Abstract]   [Full Text] [Related]  

  • 10. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study.
    Kohara K; Fujisawa M; Ando F; Tabara Y; Niino N; Miki T; Shimokata H;
    Stroke; 2003 May; 34(5):1130-5. PubMed ID: 12690212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amprenavir and lopinavir pharmacokinetics following coadministration of amprenavir or fosamprenavir with lopinavir/ritonavir, with or without efavirenz.
    Pham PA; Hendrix CW; Barditch-Crovo P; Parsons T; Khan W; Parish M; Radebaugh C; Carson KA; Pakes GE; Qaqish R; Flexner C
    Antivir Ther; 2007; 12(6):963-9. PubMed ID: 17926651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical importance of pharmacokinetics].
    Palma-Aguirre JA
    Gac Med Mex; 1991; 127(4):341-8. PubMed ID: 1790843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury in Mouse Brain.
    Li Y; Tang G; Liu Y; He X; Huang J; Lin X; Zhang Z; Yang GY; Wang Y
    Stem Cells Transl Med; 2015 Oct; 4(10):1122-30. PubMed ID: 26253714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal pharmacology--pharmacokinetics.
    Johnson PJ
    Neonatal Netw; 2011 Jan-Feb 1; 30(1):54-61. PubMed ID: 21317099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.
    Kusawake T; Keirns JJ; Kowalski D; den Adel M; Groenendaal-van de Meent D; Takada A; Ohtsu Y; Katashima M
    Adv Ther; 2017 Dec; 34(12):2625-2637. PubMed ID: 29134426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.
    Mustafa S; Yusuf WN; Woillard JB; Choon TS; Hassan NB
    Eur J Clin Pharmacol; 2016 Jul; 72(7):831-8. PubMed ID: 27025609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of pharmacokinetics and pharmacodynamics.
    Scharf S; Christophidis N
    Med J Aust; 1993 Mar; 158(6):395-402. PubMed ID: 8479353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacokinetic methods. II: Determination of the presence or absence of product inhibition in drugs with nonlinear pharmacokinetics.
    Browne TR; Szabo GK; Walsh CT; Schumacher GE; Evans JE; Evans BA
    J Clin Pharmacol; 1990 Jul; 30(7):578-84. PubMed ID: 2391390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic pharmacokinetics and the potential effect of physical therapy interventions on pharmacokinetic variables.
    Ciccone CD
    Phys Ther; 1995 May; 75(5):343-51. PubMed ID: 7732078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncompartmental versus compartmental modelling in clinical pharmacokinetics.
    Gillespie WR
    Clin Pharmacokinet; 1991 Apr; 20(4):253-62. PubMed ID: 2036746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.